Switch theme
Sign up to access all valuation multiples
Cell Impact develops technologies to produce flow plates for fuel cells. It provides graphite, stainless steel, and titanium flow plates. The company has developed and patented a method for high-velocity forming, Cell Impact Forming that makes it possible to produce flow plates with more advanced designs, which in turn creates more cost and energy-efficient fuel cells compared to conventional molding methods. Geographically, it operates in Sweden, Asia, U.S. and Other Europe.
1999
41
LTM Revenue $2.9M
LTM EBITDA -$6.6M
$5.5M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Cell Impact has a last 12-month revenue (LTM) of $2.9M and a last 12-month EBITDA of -$6.6M.
In the most recent fiscal year, Cell Impact achieved revenue of $3.9M and an EBITDA of -$6.9M.
Cell Impact expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Cell Impact valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $2.9M | XXX | $3.9M | XXX | XXX | XXX |
| Gross Profit | $2.9M | XXX | $0.6M | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 15% | XXX | XXX | XXX |
| EBITDA | -$6.6M | XXX | -$6.9M | XXX | XXX | XXX |
| EBITDA Margin | -227% | XXX | -178% | XXX | XXX | XXX |
| EBIT | -$9.7M | XXX | -$10.2M | XXX | XXX | XXX |
| EBIT Margin | -334% | XXX | -265% | XXX | XXX | XXX |
| Net Profit | -$9.9M | XXX | -$10.4M | XXX | XXX | XXX |
| Net Margin | -341% | XXX | -269% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Cell Impact's stock price is SEK 0 (or $0).
Cell Impact has current market cap of SEK 31.2M (or $3.2M), and EV of SEK 53.2M (or $5.5M).
See Cell Impact trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5.5M | $3.2M | XXX | XXX | XXX | XXX | $-0.01 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Cell Impact has market cap of $3.2M and EV of $5.5M.
Cell Impact's trades at 1.4x EV/Revenue multiple, and -0.8x EV/EBITDA.
Equity research analysts estimate Cell Impact's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Cell Impact has a P/E ratio of -0.3x.
See valuation multiples for Cell Impact and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3.2M | XXX | $3.2M | XXX | XXX | XXX |
| EV (current) | $5.5M | XXX | $5.5M | XXX | XXX | XXX |
| EV/Revenue | 1.9x | XXX | 1.4x | XXX | XXX | XXX |
| EV/EBITDA | -0.8x | XXX | -0.8x | XXX | XXX | XXX |
| EV/EBIT | -0.6x | XXX | -0.5x | XXX | XXX | XXX |
| EV/Gross Profit | 1.9x | XXX | n/a | XXX | XXX | XXX |
| P/E | -0.3x | XXX | -0.3x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -0.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialCell Impact's last 12 month revenue growth is -9%
Cell Impact's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.3M for the same period.
Cell Impact's rule of 40 is -210% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Cell Impact's rule of X is -250% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Cell Impact and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | -9% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Margin | -227% | XXX | -178% | XXX | XXX | XXX |
| EBITDA Growth | -23% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -210% | XXX | -188% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | -250% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 280% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| AMG Critical Materials | XXX | XXX | XXX | XXX | XXX | XXX |
| ArcelorMittal | XXX | XXX | XXX | XXX | XXX | XXX |
| BHP Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Coronado Global Resources | XXX | XXX | XXX | XXX | XXX | XXX |
| Fortescue | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Cell Impact acquired XXX companies to date.
Last acquisition by Cell Impact was XXXXXXXX, XXXXX XXXXX XXXXXX . Cell Impact acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Cell Impact founded? | Cell Impact was founded in 1999. |
| Where is Cell Impact headquartered? | Cell Impact is headquartered in Sweden. |
| How many employees does Cell Impact have? | As of today, Cell Impact has 41 employees. |
| Is Cell Impact publicy listed? | Yes, Cell Impact is a public company listed on STO. |
| What is the stock symbol of Cell Impact? | Cell Impact trades under CI ticker. |
| When did Cell Impact go public? | Cell Impact went public in 2013. |
| Who are competitors of Cell Impact? | Similar companies to Cell Impact include e.g. AMG Critical Materials, ArcelorMittal, BHP Group, Coronado Global Resources. |
| What is the current market cap of Cell Impact? | Cell Impact's current market cap is $3.2M |
| What is the current revenue of Cell Impact? | Cell Impact's last 12 months revenue is $2.9M. |
| What is the current revenue growth of Cell Impact? | Cell Impact revenue growth (NTM/LTM) is -9%. |
| What is the current EV/Revenue multiple of Cell Impact? | Current revenue multiple of Cell Impact is 1.9x. |
| Is Cell Impact profitable? | Yes, Cell Impact is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Cell Impact? | Cell Impact's last 12 months EBITDA is -$6.6M. |
| What is Cell Impact's EBITDA margin? | Cell Impact's last 12 months EBITDA margin is -227%. |
| What is the current EV/EBITDA multiple of Cell Impact? | Current EBITDA multiple of Cell Impact is -0.8x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
